Klaas Financial Asset Advisors, LLC Johnson & Johnson Transaction History

Klaas Financial Asset Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $6,325 - $7,183	-40 Reduced 15.81%	213 $38,000
Q4 2021 Feb 09, 2022	BUY	$155.93 - $173.01 $6,393 - $7,093	41 Added 19.34%	253 $43,000
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $161 - $179	1 Added 0.47%	212 $34,000
Q2 2021 Jul 28, 2021	BUY	$159.48 - $171.07 $318 - $342	2 Added 0.96%	211 $35,000
Q1 2021 Apr 20, 2021	SELL	$153.07 - $170.48 $2,755 - $3,068	-18 Reduced 7.93%	209 $34,000
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $31,123 - $35,725	227 New	227 $36,000

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Klaas Financial Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Klaas Financial Asset Advisors, LLC with notifications on news.